Spontaneous Growth Hormone (GH) Secretion and Results of Therapy with GH in Thalassemic Patients
Life expectancy for patients with thalassemia major (TM) has greatly improved, and their hopes are now directed towards attainment of better quality of life. The growth retardation of many of these patient becomes a major concern for the patients, their families, and the medical care-giver.
KeywordsGrowth Hormone Growth Hormone Response Growth Hormone Therapy Thalassemic Patient Thalassemia Major
Unable to display preview. Download preview PDF.
- 1.Shehadeh N, Hazani A, Rudolf MCJ, Peleg I, Benderly A, Hochberg (1990) Neurosecretory dysfunction of growth hormone secretion in thalassemia major. Acta Paediatr Scand 79: 790–795Google Scholar
- 2.Scacchi M, Danesi L, De Martin M, Dubini A, Forni L, Masala A, Gallisai D, Burrai C, Terzoli S, Boffa C, Marzano C, Cavagnini F (1991) Treatment with biosynthetic growth hormone of short thalassemic patients with impaired growth hormone secretion. Clin Endocrinol (Oxf.) 35: 335–339CrossRefGoogle Scholar
- 4.Johnston FE, Hertzog KP, Malina RM (1966) Longitudinal growth in thalassemia major. Am J Dis Child 122: 396–399Google Scholar